Trial Profile
Use of Clinical and Intermediate Phenotypes to Assess Response to Quetiapine: the Role of Putative Causative Genes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Pharmacogenomic; Therapeutic Use
- 12 May 2016 Status changed from discontinued to completed.
- 23 Jun 2012 Status changed from suspended to discontinued as reported by European Clinical Trials Database.
- 23 Jun 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2009-013028-21).